Acetylcholinesterase Blockade Does Not Account for the Adverse Cardiovascular Effects of the Antitumor Drug Irinotecan: A Preclinical Study

Author: Blandizzi C.   De Paolis B.   Colucci R.   Di Paolo A.   Danesi R.   Del Tacca M.  

Publisher: Elsevier

ISSN: 0041-008X

Source: Toxicology and Applied Pharmacology, Vol.177, Iss.2, 2001-12, pp. : 149-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract